Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « ISSN » - entrée « 1365-2125 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1365-2060 < 1365-2125 < 1365-2141  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000789 (2020) Venkatesh Pilla Reddy ; Eman El-Khateeb ; Heeseung Jo ; Natalie Giovino ; Emily Lythgoe ; Shringi Sharma ; Weifeng Tang ; Masoud Jamei ; Amin Rastomi-HodjeganPharmacokinetics under the COVID-19 storm.
000931 (2021) Jun Shi ; Yubo Xiao ; Yiting Zhang ; Donghao Geng ; Danhua Cong ; Kevin X. Shi ; Richard J. KnappChallenges of drug development during the COVID-19 pandemic: Key considerations for clinical trial designs.
000A50 (2021) Daniela R. Junqueira ; Brian H. RoweEfficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic.
000B65 (2021) Adam Goldman ; David Bomze ; Rachel Dankner ; Hanoch Hod ; Tomer Meirson ; Ben Boursi ; Elad MaorCardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
001095 (2021) Mary Kelly ; R Isìn O'Connor ; Liam Townsend ; Miriam Coghlan ; Eileen Relihan ; Miriam Moriarty ; Bernard Carr ; Gail Melanophy ; Caitriona Doyle ; Ciaran Bannan ; Ruth O'Riordan ; Concepta Merry ; Susie Clarke ; Colm BerginClinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin.
001368 (2021) Pauline Thémans ; Nicolas Dauby ; Loïc Schrooyen ; Faustine Lebout ; Marc Delforge ; Rakan Nasreddine ; Agnès Libois ; Marie-Christine Payen ; Déborah Konopnicki ; Francoise Wuillaume ; Cecile Lescrainier ; Veerle Verlinden ; Jean-Michel Dogné ; Jamila Hamdani ; Flora T. MusuambaModel informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gaps.
001837 (2020) Hervé Javelot ; Wissam El-Hage ; Guillaume Meyer ; Guillaume Becker ; Bruno Michel ; Coraline HingrayCOVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i -k "1365-2125" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i  \
                -Sk "1365-2125" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1365-2125
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021